1. Home
  2. TECX vs CTO Comparison

TECX vs CTO Comparison

Compare TECX & CTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$30.82

Market Cap

545.3M

Sector

N/A

ML Signal

HOLD

Logo CTO Realty Growth Inc.

CTO

CTO Realty Growth Inc.

HOLD

Current Price

$19.54

Market Cap

599.1M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
CTO
Founded
2019
1902
Country
United States
United States
Employees
60
42
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
545.3M
599.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TECX
CTO
Price
$30.82
$19.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$75.25
$21.50
AVG Volume (30 Days)
167.5K
186.7K
Earning Date
05-07-2026
04-28-2026
Dividend Yield
N/A
7.78%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$7.63
Revenue Next Year
N/A
$2.76
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.39
$15.07
52 Week High
$35.99
$20.25

Technical Indicators

Market Signals
Indicator
TECX
CTO
Relative Strength Index (RSI) 56.04 61.66
Support Level $17.71 $19.16
Resistance Level $32.27 $19.82
Average True Range (ATR) 1.52 0.30
MACD -0.24 0.12
Stochastic Oscillator 68.80 86.31

Price Performance

Historical Comparison
TECX
CTO

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About CTO CTO Realty Growth Inc.

CTO Realty Growth Inc is a real estate investment trust company, that owns income properties in diversified markets in the United States. The company operates in four primary business segments: Income properties, management services, commercial loans and investments, and real estate operations. It derives maximum revenue from Income Properties.

Share on Social Networks: